Clinical Trial Update: DYmista NAsal Spray in CHInese Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for DYmista Nasal Spray in Chinese patients with allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Dymista Nasal Spray (azelastine hydrochloride and fluticasone propionate nasal spray)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED